logo
  

Cardinal Health Gets FDA Approval For Lymphoseek Pediatric Indication

Cardinal Health (CAH) said that the U.S. Food and Drug Administration has approved Lymphoseek (technetium Tc 99m tilmanocept) injection for pediatric use. Lymphoseek is radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies or SLNB.

In addition to adult use, the new indication will provide lymph node identification in pediatric patients with melanoma, rhabdomyosarcoma or other types of solid tumors. This will offer physicians, oncologists and nuclear medicine specialists an efficient, accurate and safe option to enhance lymphatic mapping and SLNB in pediatric melanoma cases, the most common skin cancer in children.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT